Consistent with our founder's vision (see statement), the research of the Ludwig Institute for Cancer Research is conducted at multiple sites rather than at a single location. This model of a global network was chosen to facilitate the worldwide recruitment of outstanding scientists and clinicians, and to draw on the different strengths of a variety of laboratory, clinical, and cultural environments. The Branch staffs, Affiliates, James R. Kerr Program participants and Clinical Trials Center investigators interact closely and strategically to further the research and clinical programs of LICR.
Branches
The Institute's nine Branches and its Center for Clinical Sciences are located in seven different countries. Each functions in close association with a leading university or research institute, and a not-for-profit teaching hospital, thus enabling LICR investigators to interact closely with investigators in a wide variety of disciplines. Through laboratory and clinical collaborations, teaching activities, and the training of graduate students, LICR has become an integral part of the academic life of many exceptional institutions.
Affiliates
Affiliates are outstanding scientific and clinical investigators and institutions that are outside the Branch structure, but are closely associated with LICR. The work of the Affiliates complements and extends the research conducted within the Branches, and contributes significantly to LICR's programs.
Clinical Trials Sites
The LICR conducts clinical trials at a number of sites that combine excellent patient care with cutting-edge research and treatment to develop and refine therapies generated by the LICR research programs.
James R. Kerr Program Laboratories
The James R. Kerr Program establishes and coordinates collaborations at leading academic centers in countries that are scientifically talented but have had limited opportunities to establish international collaborations. The James R. Kerr Program Investigators are currently located in China, Russia, South Africa, Turkey, and the Ukraine. Through the James R. Kerr Program, LICR continues to identify and recruit outstanding scientists wherever they may be found
Ludwig Centers
Mr. Daniel K. Ludwig's commitment to cancer research did not end with the establishment of the Ludwig Institute for Cancer Research. He also endowed the Virginia and D.K. Ludwig Fund for Cancer Research, which has created Ludwig Centers at six preeminent academic institutions in the United States of America: The Dana-Farber Institute at Harvard Medical School, Johns Hopkins Medical School, Massachusetts Institute of Technology, Memorial Sloan-Kettering Cancer Center, Stanford University, and University of Chicago.